A report states that the Indian coronary stent market comprises Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bio-Absorbable Stent (BVS) will be tripled by 2021. High number of coronary angioplasties due to the increase in cardiovascular diseases, number of interventional cardiologists and cath labs in government and private hospitals, individual cath lab centres makes the growth of the market very impressive.

The report reviewed historical trends and forecasts  (2007 and 2020), competitive landscape, market size, market growth, pricing, annualised sales, and market share.